Nearly half of Alzheimer’s disease patients treated with TrueBinding’s investigational therapy TB006 for at least three months showed signs of disease reversal or cognitive improvement, according to ...

While there is no cure for Alzheimer’s disease, nor have any disease-modifying therapies been approved yet, there are several medications available by prescription to treat disease symptoms that ...

Alzheimer’s disease affects every aspect of a person’s being, altering personality and behaviors. A loved one diagnosed with dementia may behave irrationally or rudely toward family members, ...

Alzheimer’s disease (AD) is associated with a gradual decline in memory and mental ability, due to the accumulation and spread of damage in the brain. It is an irreversible condition, with symptoms ...

“This is excellent news for the 3+ million Americans currently taking lithium-based treatments,” Stephan Jackman, CEO of Alzamend, said in a press release.. AL001 (also known as LiProSal) is an ionic ...

The therapy’s development has been both unusual and tumultuous. Data from an early Phase 1b clinical trial called PRIME (NCT01677572) suggested that the treatment could safely slow cognitive decline, ...

“This first regulatory approval for AlzoSure Predict … represents a significant advance for the millions of patients and their families in Europe at risk from Alzheimer’s disease,” Paul Kinnon, CEO of ...

A carpenter wouldn’t show up to work without a belt full of essential tools specific to carpentry. Caring for a loved one at home requires an arsenal of tools specific to the jobs that caregiving ...

When Lewis Hornby’s grandmother was rushed to the hospital in 2018, his family feared the worst. Pat Dickinson suffered from dementia, but in this instance it turned out that she was simply dehydrated ...

According to the JAMA study, veterans exposed to Agent Orange are twice as likely to be diagnosed with dementia, compared with veterans who were not exposed.Those who were exposed also developed ...

The test, developed by Roche in collaboration with Eli Lilly, is intended to support a more accurate Alzheimer’s diagnosis in adults, ages 60 and older, when used with other clinical assessments..

Alzheimer’s is a brain disease. People diagnosed with Alzheimer’s disease may display similar traits to those with mental illness. However, Alzheimer’s disease is more accurately defined as a brain ...